William J Chase insider trades

Open-market stock purchases and sales by William J Chase, Director at GRAIL, Inc, from SEC Form 4 filings since Feb 7, 2013.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +178%.

Recent trades

DateStockTradeValue
Jun 18, 2026GRAL GRAIL, IncBought (not open market)$350K
Jun 9, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jun 9, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Apr 15, 2026GRAL GRAIL, IncBought (not open market)$20.3K
Jan 15, 2026GRAL GRAIL, IncBought (not open market)$20.8K
Oct 15, 2025GRAL GRAIL, IncBought (not open market)$20.8K

Companies traded

  • GRAL GRAIL, Inc: other filings, last Jun 18, 2026
  • NTLA Intellia Therapeutics, Inc: 1 buy, last Jun 9, 2026
  • ABBV AbbVie Inc: 1 buy, 9 sales, last Jun 26, 2019

Get free alerts when William J Chase files a new trade →